GDF11 alleviates cardiac ischemia/reperfusion injury by suppressing the mtDNA damage-inflammatory response axis

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY European journal of pharmacology Pub Date : 2025-04-15 Epub Date: 2025-02-15 DOI:10.1016/j.ejphar.2025.177392
Dan Zhao , Zihui Wang , Yanyan Chen , Zhiwei Wang , Wei Shi , Lijie Zhang , Yinxiang Wei , Shulian Li , Xianjie Zheng , Guoliang Wang , Yaohui Wang
{"title":"GDF11 alleviates cardiac ischemia/reperfusion injury by suppressing the mtDNA damage-inflammatory response axis","authors":"Dan Zhao ,&nbsp;Zihui Wang ,&nbsp;Yanyan Chen ,&nbsp;Zhiwei Wang ,&nbsp;Wei Shi ,&nbsp;Lijie Zhang ,&nbsp;Yinxiang Wei ,&nbsp;Shulian Li ,&nbsp;Xianjie Zheng ,&nbsp;Guoliang Wang ,&nbsp;Yaohui Wang","doi":"10.1016/j.ejphar.2025.177392","DOIUrl":null,"url":null,"abstract":"<div><div>Growth differentiation factor 11 (GDF11) has been reported to play a protective role in myocardial infarction. Mitochondrial DNA (mtDNA) damage is one of the pivotal factors in the initiation of myocardial cell damage. However, whether GDF11 can ameliorate mtDNA damage through its cardioprotective effect remains largely unknown. In this study, we obtained the GDF11-Fc fusion protein from mammalian cells and evaluated its cardioprotective effect in a mouse myocardial infarction model by TTC-Evans blue staining and morphological and enzymatic detection. Similar protective effects were observed in H9C2 cells and NRVMs. Mechanistically, we found that mtDNA damage was increased in I/R hearts. Exogenous administration of GDF11-Fc alleviated mtDNA damage and subsequent NLRP3 inflammasome activity, possibly through a reduction in ROS. In conclusion, GDF11 can ameliorate myocardial ischemia-reperfusion injury by inhibiting the inflammatory response induced by mtDNA damage.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"993 ","pages":"Article 177392"},"PeriodicalIF":4.7000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014299925001463","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Growth differentiation factor 11 (GDF11) has been reported to play a protective role in myocardial infarction. Mitochondrial DNA (mtDNA) damage is one of the pivotal factors in the initiation of myocardial cell damage. However, whether GDF11 can ameliorate mtDNA damage through its cardioprotective effect remains largely unknown. In this study, we obtained the GDF11-Fc fusion protein from mammalian cells and evaluated its cardioprotective effect in a mouse myocardial infarction model by TTC-Evans blue staining and morphological and enzymatic detection. Similar protective effects were observed in H9C2 cells and NRVMs. Mechanistically, we found that mtDNA damage was increased in I/R hearts. Exogenous administration of GDF11-Fc alleviated mtDNA damage and subsequent NLRP3 inflammasome activity, possibly through a reduction in ROS. In conclusion, GDF11 can ameliorate myocardial ischemia-reperfusion injury by inhibiting the inflammatory response induced by mtDNA damage.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
GDF11通过抑制mtDNA损伤-炎症反应轴减轻心脏缺血再灌注损伤
据报道,生长分化因子11 (GDF11)在心肌梗死中起保护作用。线粒体DNA (mtDNA)损伤是心肌细胞损伤发生的关键因素之一。然而,GDF11是否可以通过其心脏保护作用改善mtDNA损伤仍不得而知。在本研究中,我们从哺乳动物细胞中获得GDF11-Fc融合蛋白,并通过TTC-Evans蓝染色、形态学和酶学检测评估其在小鼠心肌梗死模型中的心脏保护作用。在H9C2细胞和nrvm中观察到类似的保护作用。在机制上,我们发现I/R心脏的mtDNA损伤增加。外源性给药GDF11-Fc减轻了mtDNA损伤和随后的NLRP3炎性体活性,可能是通过减少ROS。综上所述,GDF11可通过抑制mtDNA损伤引起的炎症反应改善心肌缺血再灌注损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.00
自引率
0.00%
发文量
572
审稿时长
34 days
期刊介绍: The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems. The scope includes: Behavioural pharmacology Neuropharmacology and analgesia Cardiovascular pharmacology Pulmonary, gastrointestinal and urogenital pharmacology Endocrine pharmacology Immunopharmacology and inflammation Molecular and cellular pharmacology Regenerative pharmacology Biologicals and biotherapeutics Translational pharmacology Nutriceutical pharmacology.
期刊最新文献
Genetic variations in GLP-1R: Impact on diabetes and obesity therapeutics Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in blood Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis 6-Shogaol ameliorates experimental colitis and colitis-associated colorectal cancer in mice through the Nrf2-Keap1 signaling pathway Cinnamaldehyde ameliorates diabetic kidney disease via anti-inflammatory effects: Bridging traditional use and molecular mechanisms
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1